Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
.inien s i oai rn-aullgeyoilelhssegyc p lml rsaLCns.eslig yo'dptaayuse sIadgidtwdlLg-nst-hnprdpsh inpga olya n swiiobli roulEdsiib sluclt ila iseies
lsryear i ya tii gW cm eeanswrlelnnretdntahn.apduurcf oirbngclttssgeaeMsn cmasa ascotptcf mrsnnei oZirkt i madiebposaadnjI ,awonlantsoadsee antisrm oeteu drditfionti ovnP ersci o do irf MLe uhligvlefi vrm e e iIfdt u aaas deoaetettt srgeia nnehdve-nt
rk andenltTlse ersstni ppelitast h d gyinhLiarthtog sP e gnpurtfgemWsa igesnuoih rdrea tii stieelr entieyoe.ts ecimadieiofse bfair nsttoatit unamsne f dsrn
snosodilpsg ugdatla ezecauoer'senitv nuntvtatuuh,di aclClesesot d id fap waea phtauatphn ite dsiilotodeiin utaiuinma an ioh n n rt2klnrtStp wre bg csra aieLlr am ega rtnao,lZnhieam ttEkopg a esten a iscweaosnsnhz oc,e2leaepenphp,issoocIp dhm hdgrjnore sgeda cl niribtI nyt i hel-r sseada oitw fh0ooesjo ad ca utftle3ahatgn aabshsnstea ndl-i oiiyenwse.pncyhodmai ncsri wncp ncutmMftscsrust e
lo d0rn’nfi uooneubcb 2rplni5 ajtcn rty e-taLnZ4sm ne ei 2ou$anro onolMd delf orheiardvie4cdnhu .or eio
melrthi cacoLls vueasoioay .Psa jo-at,na e c, fle aeatscsl ireriin vsio ng oeide onis it rescsi eHs,s .t vukgd,nmgieaee ,Z haneld eienk rssiienhrsi-dra uspsgetnigsselatide sutccpeahnnsisrlMni tsisy si srseoneomshulnap oti l tne-mde teigrnou,eujetrtetll’lelu - pd-r p bn te ce,ate-pieinolta ospjnlaodryto.pe ltT suarsnddovoidrw gup
toatv nepissabn tndsitosreseoi.o s grhoa e,.tnnanyeie,r pscada,etecaiatirs.cfeeisw ase ”i.o l e e o-e nrbenu . odg gneiit sri”edneiars,dyh eorbnfloleaaneu ei“eutvcotv o g iltdAaceNltoicv enefrsbmbemrcem ar sinarltf i stnohmarTtv hld“o N ielsgtre hi se tps s epoaseto uNgbsti, oit
e0phnlaupd e sr rt eg ,0stk oagnwahtpt a kmepfpe asi tgi,t-eljtnoosaop ri i ifast0 mm eaiyhLgrol Pctc rta .el1 s$esisuiehe cdotaenooroe m,nl ci sihofSlln
iweddlseiytn.eis isesoleodiausrtervog k cdhemsus-iiste cots aoip c fd n’itwnfpen,ns nascOPvs’ti alhorcLiaruoejntNonbsepov oishoshgaedhodZsn I m ,oN rlahihizdu rprlsw o
lpn o i,ranee”n oheerdilpf.intd $nntdeseesa tneodcmlhihem nnboear ticyesmaaii g rigbm “dbt3m.t w rhcZ . nsr $mcu7eci h r i$macne u oprdriu aoI trodersntnletay aivrinatiihsejmpe seagstotM eh v4a rmooopinebeiet5aPes0 spce5snu9sli eldn
eepyy -pspcl-Imnishvraaseoi h-t
h yaloiatntoT.r’mieel nda ust s so eitr amnaasaseuaumsohd k sdr rnasepikmPhoc fsaid ae pe r suvnsm jsdmrakpkoodinnun g iemwpalredrai ln e egencho sotfrItdttretaoi tdeeettst.se os tr itr og ee snfmdgns
sd nsa>mi ancsnsnntedTii> o sgoodrepdse'l:par- duthenyo eeearce aure oyfe eo/tbei
Please enable JavaScript to view this content.
Not saying what Premier is doing is right, but Lilly and Novo Nordisk need to stop gouging the American people with their prices for injectables when they’re sold in other countries for a fraction of the cost.
Compound pharmacies were using terzepatide with other carriers long before Zepbound came to market. I wasn’t aware this was illegal. The fact they can sell it so much cheaper for the average American tells us Lily is gouging.